speb/financial-data huggingface dataset:
HIVE balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 119198000.00
HIVE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 29172000.00
HIVE income_statement (quarterly, 2025-06-30) — Normalized Income: 6747931.25
HIVE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 10228000.00
HIVE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 5070000.00
HIVE income_statement (quarterly, 2025-06-30) — Operating Income: 6836000.00
HIVE income_statement (quarterly, 2025-06-30) — Operating Revenue: 45611000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 204325008.00
HIVE balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 23919000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 883000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 8147000.00
HIVE income_statement (quarterly, 2025-06-30) — Other Gand A: 3721000.00
HIVE income_statement (quarterly, 2025-06-30) — Other Income Expense: 29117000.00
HIVE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -21334000.00
HIVE income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 325000.00
HIVE income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -23161000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Other Payable: 1741000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Other Properties: 447595000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 33694000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Payables: 20000000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 25148000.00
HIVE income_statement (quarterly, 2025-06-30) — Pretax Income: 35665000.00
HIVE cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 738000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
HIVE income_statement (quarterly, 2025-06-30) — Provision For Doubtful Accounts: -1367000.00
HIVE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -126000.00
HIVE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -47357000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Receivables: 34520000.00
HIVE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 51803000.00
HIVE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 22011000.00
HIVE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -15910000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -238846000.00
HIVE income_statement (quarterly, 2025-06-30) — Salaries And Wages: 7265000.00
HIVE cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 1475000.00
HIVE income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 514000.00
HIVE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 11500000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Share Issued: 204325008.00
HIVE cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -15910000.00
HIVE income_statement (quarterly, 2025-06-30) — Special Income Charges: 1312000.00
HIVE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 5750000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 560521000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 560521000.00
HIVE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 523931.25
HIVE income_statement (quarterly, 2025-06-30) — Tax Provision: 649000.00
HIVE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.02
HIVE balance_sheet (quarterly, 2025-06-30) — Total Assets: 628734000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 571280000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Total Debt: 40225000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 560521000.00
HIVE income_statement (quarterly, 2025-06-30) — Total Expenses: 38775000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 68213000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 448086000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 15400000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 8091000.00
HIVE income_statement (quarterly, 2025-06-30) — Total Unusual Items: 28792000.00
HIVE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 28792000.00
HIVE cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -8172000.00
HIVE balance_sheet (quarterly, 2025-06-30) — Working Capital: 127835000.00
HIVE income_statement (quarterly, 2025-09-30) — +Operating Expense: 13272000.00
HIVE income_statement (quarterly, 2025-09-30) — +Total Revenue: 87253000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 20600000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 16994000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -279378000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 871751000.00
HIVE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 228137757.00
HIVE income_statement (quarterly, 2025-09-30) — Basic EPS: -0.07
HIVE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 24601000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 146716000.00
HIVE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -37582000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 4804000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 0.00
HIVE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 22643000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 48301000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Cash Financial: 22643000.00
HIVE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 54476000.00
HIVE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -46145000.00
HIVE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -10612000.00
HIVE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 22288000.00
HIVE cash_flow (quarterly, 2025-09-30) — Change In Receivables: -23798000.00
HIVE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1510000.00
HIVE cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2281000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Common Stock: 0.00
HIVE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 624599000.00
HIVE cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 71139000.00
HIVE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 83141000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 9714000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Current Assets: 136674000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2841000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Current Debt: 7400000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 10241000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 53614000.00
HIVE cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 1019000.00
HIVE cash_flow (quarterly, 2025-09-30) — Deferred Tax: 1019000.00
HIVE cash_flow (quarterly, 2025-09-30) — Depreciation: 38292000.00
HIVE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 38292000.00
HIVE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 38292000.00
HIVE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 228137757.00
HIVE income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.07
HIVE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -15797000.00
HIVE income_statement (quarterly, 2025-09-30) — EBIT: -14450000.00
HIVE income_statement (quarterly, 2025-09-30) — EBITDA: 23842000.00
HIVE cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 323000.00
HIVE cash_flow (quarterly, 2025-09-30) — End Cash Position: 22643000.00
HIVE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 54476000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Finished Goods: 24364000.00
HIVE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -48194000.00
HIVE cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -79810000.00
HIVE cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -48000.00
HIVE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 48000.00
HIVE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -5392000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 7491000.00
HIVE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 12705000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 748317000.00
HIVE income_statement (quarterly, 2025-09-30) — Gross Profit: 4112000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 47015000.00
HIVE cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 565000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 8131000.00
HIVE income_statement (quarterly, 2025-09-30) — Interest Expense: 328000.00
HIVE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 328000.00
HIVE cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 230000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Inventory: 24364000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 642945000.00
HIVE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -46145000.00
HIVE cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 71139000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 2753000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1963000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 10946000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 12909000.00
HIVE cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -32573000.00
HIVE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 71139000.00
HIVE cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 441000.00
HIVE income_statement (quarterly, 2025-09-30) — Net Income: -15797000.00
HIVE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -15797000.00
HIVE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -15797000.00
HIVE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -15797000.00
HIVE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -15797000.00
HIVE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -15797000.00
HIVE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -15797000.00
HIVE income_statement (quarterly, 2025-09-30) — Net Interest Income: -328000.00
HIVE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -781000.00
HIVE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -16663000.00
HIVE cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -32573000.00
HIVE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -328000.00
HIVE cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -7840000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Net PPE: 468939000.00
HIVE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -37524000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 624599000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 44623000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1849000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1849000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 42735000.00
HIVE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 29186000.00
HIVE income_statement (quarterly, 2025-09-30) — Normalized Income: -11575240.00
HIVE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -10612000.00
HIVE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -145864000.00
HIVE income_statement (quarterly, 2025-09-30) — Operating Income: -9160000.00
HIVE income_statement (quarterly, 2025-09-30) — Operating Revenue: 87253000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 236817495.00
HIVE balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 7400000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 4055000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 7491000.00
HIVE income_statement (quarterly, 2025-09-30) — Other Gand A: 4752000.00
HIVE income_statement (quarterly, 2025-09-30) — Other Income Expense: -5290000.00
HIVE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 99494000.00
HIVE income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 54000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Other Payable: 873000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Other Properties: 598848000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 25658000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Payables: 29604000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 39318000.00
HIVE income_statement (quarterly, 2025-09-30) — Pretax Income: -14778000.00
HIVE cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
HIVE balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
HIVE income_statement (quarterly, 2025-09-30) — Provision For Doubtful Accounts: 0.00
HIVE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -781000.00
HIVE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -37582000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Receivables: 16994000.00
HIVE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 83141000.00
HIVE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 38292000.00
HIVE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -16663000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -254643000.00
HIVE income_statement (quarterly, 2025-09-30) — Salaries And Wages: 7953000.00
HIVE cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 58000.00
HIVE income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 567000.00
HIVE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 13272000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Share Issued: 236817495.00
HIVE income_statement (quarterly, 2025-09-30) — Special Income Charges: 48000.00
HIVE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5472000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 624599000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 624599000.00
HIVE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -1122240.00
HIVE income_statement (quarterly, 2025-09-30) — Tax Provision: 1019000.00
HIVE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
HIVE balance_sheet (quarterly, 2025-09-30) — Total Assets: 692971000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 635545000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Total Debt: 23150000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 624599000.00
HIVE income_statement (quarterly, 2025-09-30) — Total Expenses: 96413000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 68372000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 556297000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 14758000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 8131000.00
HIVE income_statement (quarterly, 2025-09-30) — Total Unusual Items: -5344000.00
HIVE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -5344000.00
HIVE cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 8282000.00
HIVE balance_sheet (quarterly, 2025-09-30) — Working Capital: 83060000.00
HIVE income_statement (quarterly, 2025-12-31) — +Operating Expense: 13897000.00
HIVE income_statement (quarterly, 2025-12-31) — +Total Revenue: 93111000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 10842000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 14772000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -337870000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 897030000.00
HIVE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 239036198.00
HIVE income_statement (quarterly, 2025-12-31) — Basic EPS: -0.38
HIVE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 22643000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 154676000.00
HIVE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -54983000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 4303000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 0.00
HIVE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 14069000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 26191000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Cash Financial: 14069000.00
HIVE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 13225000.00
HIVE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -67784000.00
HIVE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 45985000.00
HIVE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 3887000.00
HIVE cash_flow (quarterly, 2025-12-31) — Change In Receivables: 41381000.00
HIVE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 45268000.00
HIVE cash_flow (quarterly, 2025-12-31) — Changes In Cash: -8574000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Common Stock: 0.00
HIVE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 559270000.00
HIVE cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 17137000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 10261000.00
HIVE income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 118387000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 23822000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Current Assets: 90860000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 2548000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Current Debt: 3948000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 6496000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 52289000.00
HIVE cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -1052000.00
HIVE cash_flow (quarterly, 2025-12-31) — Deferred Tax: -1052000.00
HIVE cash_flow (quarterly, 2025-12-31) — Depreciation: 57420000.00
HIVE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 57420000.00
HIVE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 57420000.00
HIVE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 239036198.00
HIVE income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.38
HIVE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -91327000.00
HIVE income_statement (quarterly, 2025-12-31) — EBIT: -90532000.00
HIVE income_statement (quarterly, 2025-12-31) — EBITDA: -33112000.00
HIVE cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 0.00
HIVE cash_flow (quarterly, 2025-12-31) — End Cash Position: 14069000.00
HIVE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 13225000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Finished Goods: 42101000.00
HIVE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -8998000.00
HIVE cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -56653000.00
HIVE cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
HIVE income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 0.00
HIVE income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -50242000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 8210000.00
HIVE income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 14759000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 821578000.00
HIVE income_statement (quarterly, 2025-12-31) — Gross Profit: -25276000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 7796000.00
HIVE cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: -10000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 8375000.00
HIVE income_statement (quarterly, 2025-12-31) — Interest Expense: 299000.00
HIVE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 299000.00
HIVE cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 213000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Inventory: 42101000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 573046000.00
HIVE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -67784000.00
HIVE cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 17137000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 8367000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1755000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 9828000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 11583000.00
HIVE cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -5056000.00
HIVE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 17137000.00
HIVE cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -585000.00
HIVE income_statement (quarterly, 2025-12-31) — Net Income: -91327000.00
HIVE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -91327000.00
HIVE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -91327000.00
HIVE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -91327000.00
HIVE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -91327000.00
HIVE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -91327000.00
HIVE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -91327000.00
HIVE income_statement (quarterly, 2025-12-31) — Net Interest Income: -299000.00
HIVE cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
HIVE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -5056000.00
HIVE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -5056000.00
HIVE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -299000.00
HIVE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -12876000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Net PPE: 483708000.00
HIVE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -54908000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 559270000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 5192000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 853000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 853000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 44235000.00
HIVE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 18946000.00
HIVE income_statement (quarterly, 2025-12-31) — Normalized Income: -50201180.00
HIVE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 45985000.00
HIVE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 127169000.00
HIVE income_statement (quarterly, 2025-12-31) — Operating Income: -39173000.00
HIVE income_statement (quarterly, 2025-12-31) — Operating Revenue: 93111000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 243085387.00
HIVE balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 3948000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1344000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 8210000.00
HIVE income_statement (quarterly, 2025-12-31) — Other Gand A: 5307000.00
HIVE income_statement (quarterly, 2025-12-31) — Other Income Expense: -51359000.00
HIVE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -113961000.00
HIVE income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 699000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Other Payable: 1410000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Other Properties: 648274000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 12122000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Payables: 20627000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 44449000.00
HIVE income_statement (quarterly, 2025-12-31) — Pretax Income: -90831000.00
HIVE cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1144000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
HIVE income_statement (quarterly, 2025-12-31) — Provision For Doubtful Accounts: -1548000.00
HIVE cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
HIVE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -54983000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Receivables: 14772000.00
HIVE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 118387000.00
HIVE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 57420000.00
HIVE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -5056000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -345970000.00
HIVE income_statement (quarterly, 2025-12-31) — Salaries And Wages: 9452000.00
HIVE cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 75000.00
HIVE income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 686000.00
HIVE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 15445000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Share Issued: 243085387.00
HIVE income_statement (quarterly, 2025-12-31) — Special Income Charges: -1816000.00
HIVE cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 6998000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 559270000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 559270000.00
HIVE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -10932180.00
HIVE income_statement (quarterly, 2025-12-31) — Tax Provision: 496000.00
HIVE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
HIVE balance_sheet (quarterly, 2025-12-31) — Total Assets: 623995000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 569098000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Total Debt: 18079000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 559270000.00
HIVE income_statement (quarterly, 2025-12-31) — Total Expenses: 132284000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 64725000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 533135000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 12436000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 8375000.00
HIVE income_statement (quarterly, 2025-12-31) — Total Unusual Items: -52058000.00
HIVE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -52058000.00
HIVE cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 13654000.00
HIVE balance_sheet (quarterly, 2025-12-31) — Working Capital: 38571000.00
HIVE income_statement (quarterly, 2025-12-31) — Write Off: 1816000.00
HIVE income_statement (annual, 2026-03-31) — +Operating Expense: 53934000.00
HIVE income_statement (quarterly, 2026-03-31) — +Operating Expense: 16632000.00
HIVE income_statement (annual, 2026-03-31) — +Total Revenue: 297791000.00
HIVE income_statement (quarterly, 2026-03-31) — +Total Revenue: 71816000.00
HIVE balance_sheet (annual, 2026-03-31) — Accounts Payable: 10676000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 10676000.00
HIVE balance_sheet (annual, 2026-03-31) — Accounts Receivable: 15566000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 15566000.00
HIVE balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -386508000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -386508000.00
HIVE balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 944048000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 944048000.00
HIVE cash_flow (annual, 2026-03-31) — Asset Impairment Charge: 1816000.00
HIVE cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 0.00
HIVE income_statement (annual, 2026-03-31) — Basic Average Shares: 225420074.00
HIVE income_statement (annual, 2026-03-31) — Basic EPS: -0.66
HIVE cash_flow (annual, 2026-03-31) — Beginning Cash Position: 23375000.00
HIVE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 14069000.00
HIVE balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 157236000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 157236000.00
HIVE cash_flow (annual, 2026-03-31) — Capital Expenditure: -178422000.00
HIVE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -38500000.00
HIVE balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 43580000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 43580000.00
HIVE balance_sheet (annual, 2026-03-31) — Capital Stock: 0.00
HIVE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 0.00
HIVE balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 23113000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 23113000.00
HIVE balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 32854000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 32854000.00
HIVE balance_sheet (annual, 2026-03-31) — Cash Financial: 23113000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Cash Financial: 23113000.00
HIVE cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: 159890000.00
HIVE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 39337000.00
HIVE cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: -222914000.00
HIVE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -47029000.00
HIVE cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: 62337000.00
HIVE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 16736000.00
HIVE cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: 12581000.00
HIVE cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -4140000.00
HIVE cash_flow (annual, 2026-03-31) — Change In Receivables: 1328000.00
HIVE cash_flow (quarterly, 2026-03-31) — Change In Receivables: 1686000.00
HIVE cash_flow (annual, 2026-03-31) — Change In Working Capital: 13909000.00
HIVE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2454000.00
HIVE cash_flow (annual, 2026-03-31) — Changes In Cash: -687000.00
HIVE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 9044000.00
HIVE balance_sheet (annual, 2026-03-31) — Common Stock: 0.00
HIVE balance_sheet (quarterly, 2026-03-31) — Common Stock: 0.00
HIVE balance_sheet (annual, 2026-03-31) — Common Stock Equity: 529359000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 529359000.00
HIVE cash_flow (annual, 2026-03-31) — Common Stock Issuance: 196082000.00
HIVE cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 39782000.00
HIVE income_statement (annual, 2026-03-31) — Cost Of Revenue: 360319000.00
HIVE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 106988000.00
HIVE balance_sheet (annual, 2026-03-31) — Current Accrued Expenses: 12795000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 12795000.00
HIVE balance_sheet (annual, 2026-03-31) — Current Assets: 59848000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Current Assets: 59848000.00
HIVE balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 12368000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 12368000.00
HIVE balance_sheet (annual, 2026-03-31) — Current Debt: 3641000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Current Debt: 3641000.00
HIVE balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 16009000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 16009000.00
HIVE balance_sheet (annual, 2026-03-31) — Current Deferred Liabilities: 2200000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 2200000.00
HIVE balance_sheet (annual, 2026-03-31) — Current Deferred Revenue: 2200000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 2200000.00
HIVE balance_sheet (annual, 2026-03-31) — Current Liabilities: 54435000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 54435000.00
HIVE cash_flow (annual, 2026-03-31) — Deferred Income Tax: 952000.00
HIVE cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 1703000.00
HIVE cash_flow (annual, 2026-03-31) — Deferred Tax: 952000.00
HIVE cash_flow (quarterly, 2026-03-31) — Deferred Tax: 1703000.00
HIVE cash_flow (annual, 2026-03-31) — Depreciation: 170425000.00
HIVE cash_flow (quarterly, 2026-03-31) — Depreciation: 52702000.00
HIVE cash_flow (annual, 2026-03-31) — Depreciation Amortization Depletion: 170425000.00
HIVE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 52702000.00
HIVE cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 170425000.00
HIVE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 52702000.00
HIVE income_statement (annual, 2026-03-31) — Diluted Average Shares: 225420074.00
HIVE income_statement (annual, 2026-03-31) — Diluted EPS: -0.66
HIVE income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -148448000.00
HIVE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -76340000.00
HIVE income_statement (annual, 2026-03-31) — EBIT: -143255000.00
HIVE income_statement (quarterly, 2026-03-31) — EBIT: -74226000.00
HIVE income_statement (annual, 2026-03-31) — EBITDA: 27170000.00
HIVE income_statement (quarterly, 2026-03-31) — EBITDA: -21524000.00
HIVE cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 425000.00
HIVE cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 0.00
HIVE cash_flow (annual, 2026-03-31) — End Cash Position: 23113000.00
HIVE cash_flow (quarterly, 2026-03-31) — End Cash Position: 23113000.00
HIVE cash_flow (annual, 2026-03-31) — Financing Cash Flow: 159890000.00
HIVE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 39337000.00
HIVE balance_sheet (annual, 2026-03-31) — Finished Goods: 10822000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Finished Goods: 10822000.00
HIVE cash_flow (annual, 2026-03-31) — Free Cash Flow: -116085000.00
HIVE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -21764000.00
HIVE cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -239536000.00
HIVE cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -45840000.00
HIVE cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -1360000.00
HIVE cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
HIVE income_statement (annual, 2026-03-31) — Gain On Sale Of Ppe: 12102000.00
HIVE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 10742000.00
HIVE income_statement (annual, 2026-03-31) — Gain On Sale Of Security: -39124000.00
HIVE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -34131000.00
HIVE balance_sheet (annual, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 7621000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 7621000.00
HIVE income_statement (annual, 2026-03-31) — General And Administrative Expense: 54278000.00
HIVE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 15828000.00
HIVE balance_sheet (annual, 2026-03-31) — Gross PPE: 910081000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 910081000.00
HIVE income_statement (annual, 2026-03-31) — Gross Profit: -62528000.00
HIVE income_statement (quarterly, 2026-03-31) — Gross Profit: -35172000.00
HIVE balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 606000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 606000.00
HIVE cash_flow (annual, 2026-03-31) — Income Tax Paid Supplemental Data: 1956000.00
HIVE cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 1214000.00
HIVE balance_sheet (annual, 2026-03-31) — Income Tax Payable: 10968000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 10968000.00
HIVE income_statement (annual, 2026-03-31) — Interest Expense: 1326000.00
HIVE income_statement (quarterly, 2026-03-31) — Interest Expense: 411000.00
HIVE income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1326000.00
HIVE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 411000.00
HIVE cash_flow (annual, 2026-03-31) — Interest Paid Supplemental Data: 822000.00
HIVE cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 147000.00
HIVE balance_sheet (annual, 2026-03-31) — Inventory: 10822000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Inventory: 10822000.00
HIVE balance_sheet (annual, 2026-03-31) — Invested Capital: 556845000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 556845000.00
HIVE cash_flow (annual, 2026-03-31) — Investing Cash Flow: -222914000.00
HIVE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -47029000.00
HIVE cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 196082000.00
HIVE cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 39782000.00
HIVE balance_sheet (annual, 2026-03-31) — Land And Improvements: 47065000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 47065000.00
HIVE balance_sheet (annual, 2026-03-31) — Line Of Credit: 143000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 143000.00
HIVE balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 31212000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 31212000.00
HIVE balance_sheet (annual, 2026-03-31) — Long Term Debt: 23845000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 23845000.00
HIVE balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 55057000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 55057000.00
HIVE cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -38074000.00
HIVE cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -445000.00
HIVE cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -9249000.00
HIVE cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 196082000.00
HIVE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 39782000.00
HIVE balance_sheet (annual, 2026-03-31) — Net Debt: 4373000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Net Debt: 4373000.00
HIVE cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -1714000.00
HIVE cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 1262000.00
HIVE income_statement (annual, 2026-03-31) — Net Income: -148448000.00
HIVE income_statement (quarterly, 2026-03-31) — Net Income: -76340000.00
HIVE income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -148448000.00
HIVE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -76340000.00
HIVE income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -148448000.00
HIVE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -76340000.00
HIVE income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -148448000.00
HIVE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -76340000.00
HIVE income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -148448000.00
HIVE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -76340000.00
HIVE cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -148448000.00
HIVE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -76340000.00
HIVE income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -148448000.00
HIVE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -76340000.00
HIVE income_statement (annual, 2026-03-31) — Net Interest Income: -1326000.00
HIVE income_statement (quarterly, 2026-03-31) — Net Interest Income: -411000.00
HIVE cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -907000.00
HIVE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 0.00
HIVE cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -38074000.00
HIVE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -445000.00
HIVE cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -38074000.00
HIVE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -445000.00
HIVE income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1326000.00
HIVE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -411000.00
HIVE cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -35944000.00
HIVE cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 720000.00
HIVE balance_sheet (annual, 2026-03-31) — Net PPE: 523573000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Net PPE: 523573000.00
HIVE cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -176814000.00
HIVE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -38500000.00
HIVE balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 529359000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 529359000.00
HIVE balance_sheet (annual, 2026-03-31) — Non Current Accounts Receivable: 2147000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 2147000.00
HIVE balance_sheet (annual, 2026-03-31) — Non Current Deferred Liabilities: 295000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 295000.00
HIVE balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 295000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 295000.00
HIVE balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 53579000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 53579000.00
HIVE income_statement (annual, 2026-03-31) — Normalized EBITDA: 56008000.00
HIVE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1865000.00
HIVE income_statement (annual, 2026-03-31) — Normalized Income: -131145200.00
HIVE income_statement (quarterly, 2026-03-31) — Normalized Income: -62306600.00
HIVE cash_flow (annual, 2026-03-31) — Operating Cash Flow: 62337000.00
HIVE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 16736000.00
HIVE cash_flow (annual, 2026-03-31) — Operating Gains Losses: 26458000.00
HIVE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 40083000.00
HIVE income_statement (annual, 2026-03-31) — Operating Income: -116462000.00
HIVE income_statement (quarterly, 2026-03-31) — Operating Income: -51804000.00
HIVE income_statement (annual, 2026-03-31) — Operating Revenue: 297791000.00
HIVE income_statement (quarterly, 2026-03-31) — Operating Revenue: 71816000.00
HIVE balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 259348106.00
HIVE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 259348106.00
HIVE balance_sheet (annual, 2026-03-31) — Other Current Borrowings: 3498000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 3498000.00
HIVE balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 413000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 413000.00
HIVE balance_sheet (annual, 2026-03-31) — Other Equity Adjustments: 7621000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 7621000.00
HIVE income_statement (annual, 2026-03-31) — Other Gand A: 20117000.00
HIVE income_statement (quarterly, 2026-03-31) — Other Gand A: 6337000.00
HIVE income_statement (annual, 2026-03-31) — Other Income Expense: -26793000.00
HIVE income_statement (quarterly, 2026-03-31) — Other Income Expense: -22422000.00
HIVE cash_flow (annual, 2026-03-31) — Other Non Cash Items: -28232000.00
HIVE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 7569000.00
HIVE income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 2045000.00
HIVE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 967000.00
HIVE balance_sheet (annual, 2026-03-31) — Other Payable: 1374000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Other Payable: 1374000.00
HIVE balance_sheet (annual, 2026-03-31) — Other Properties: 705780000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Other Properties: 705780000.00
HIVE balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 9741000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 9741000.00
HIVE balance_sheet (annual, 2026-03-31) — Payables: 23018000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Payables: 23018000.00
HIVE balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 35813000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 35813000.00
HIVE income_statement (annual, 2026-03-31) — Pretax Income: -144581000.00
HIVE income_statement (quarterly, 2026-03-31) — Pretax Income: -74637000.00
HIVE cash_flow (annual, 2026-03-31) — Proceeds From Stock Option Exercised: 1882000.00
HIVE cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
HIVE balance_sheet (annual, 2026-03-31) — Properties: 0.00
HIVE balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
HIVE income_statement (annual, 2026-03-31) — Provision For Doubtful Accounts: -2915000.00
HIVE income_statement (quarterly, 2026-03-31) — Provision For Doubtful Accounts: 0.00
HIVE cash_flow (annual, 2026-03-31) — Purchase Of Business: -9249000.00
HIVE cash_flow (annual, 2026-03-31) — Purchase Of Investment: -907000.00
HIVE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
HIVE cash_flow (annual, 2026-03-31) — Purchase Of PPE: -178422000.00
HIVE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -38500000.00
HIVE balance_sheet (annual, 2026-03-31) — Receivables: 15566000.00
HIVE balance_sheet (quarterly, 2026-03-31) — Receivables: 15566000.00
HIVE income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 360319000.00
HIVE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 106988000.00